COR
Ended Awarded Last action
- Contract number
- HHSF22301002T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $897,471
Award facts
- Opportunity
-
- 900000000 Solicitation number
- Contract value 100% obligated
- $897,471.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $897,471 |
About this award
This is a $897,471 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. LBERI, a non-profit contract research organization, will provide preclinical research services to support the development of treatments and cures for respiratory diseases. The contract has no set-aside designation and the period of performance runs through June 30, 2017. LBERI has experience supporting the National Institutes of Health (NIH), the Biomedical Advanced Research and Development Authority (BARDA), and other federal customers through prime contracts and subcontracts.
Quick answers
Who was awarded contract HHSF22301002T?
HHSF22301002T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 27, 2015.
How much is contract HHSF22301002T worth?
The government has obligated $897,471 on HHSF22301002T.
Is contract HHSF22301002T an order under another contract?
Yes. HHSF22301002T is a delivery order under HHSF223201510001I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301002T competed?
The extent of competition for HHSF22301002T was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award